tiprankstipranks
SK bioscience Co.,Ltd. (KR:302440)
:302440
South Korea Market
302440
SK bioscience Co.,Ltd.
RESEARCH TOOLSreports

SK bioscience Co.,Ltd. (302440) Financial Statements

― Followers

SK bioscience Co.,Ltd. Financial Overview

SK bioscience Co.,Ltd.'s market cap is currently ₩2.92T. The company's EPS TTM is $-1066.27; its P/E ratio is -35.45; SK bioscience Co.,Ltd. is scheduled to report earnings on August 10, 2026, and the estimated EPS forecast is $-453.86. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 651.37B₩ 267.55B₩ 369.51B₩ 456.73B₩ 929.00B
Gross Profit₩ 59.49B₩ 30.98B₩ 141.82B₩ 239.61B₩ 570.28B
Operating Income₩ -151.33B₩ -138.43B₩ -4.73B₩ 115.01B₩ 474.22B
EBITDA₩ -60.31B₩ -36.20B₩ 43.49B₩ 171.43B₩ 493.00B
Net Income₩ -56.17B₩ -53.88B₩ 22.32B₩ 122.45B₩ 355.14B
Balance Sheet
Cash & Short-Term Investments₩ 906.30B₩ 1.16T₩ 1.27T₩ 1.48T₩ 1.65T
Total Assets₩ 2.96T₩ 2.84T₩ 1.85T₩ 2.14T₩ 2.11T
Total Debt₩ 469.99B₩ 392.81B₩ 20.57B₩ 113.34B₩ 106.24B
Net Debt₩ 364.43B₩ 80.11B₩ -106.45B₩ -111.95B₩ 8.21B
Total Liabilities₩ 918.29B₩ 821.14B₩ 148.58B₩ 400.23B₩ 508.81B
Stockholders' Equity₩ 1.79T₩ 1.80T₩ 1.70T₩ 1.74T₩ 1.60T
Cash Flow
Free Cash Flow₩ -80.58B₩ -300.24B₩ -20.95B₩ -201.45B₩ 492.12B
Operating Cash Flow₩ 102.51B₩ -128.02B₩ 29.35B₩ -124.96B₩ 536.59B
Investing Cash Flow₩ -361.76B₩ 53.56B₩ -45.28B₩ 272.65B₩ -1.42T
Financing Cash Flow₩ 41.60B₩ 252.48B₩ -89.58B₩ -19.87B₩ 958.38B
Currency in KRW

SK bioscience Co.,Ltd. Earnings and Revenue History

Income Statement >

SK bioscience Co.,Ltd. Debt to Assets

Balance Sheet >

SK bioscience Co.,Ltd. Cash Flow

Cash Flow >

SK bioscience Co.,Ltd. Forecast EPS vs Actual EPS

Earnings >